Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
6796.TW
STRONG SELLREMOVEMedimaging Integrated Solution Inc. · Healthcare · Taiwan · $75M · Avg Vol: $182K/d
Medimaging Integrated Solutions does not align with our high-conviction healthcare themes. It lacks the scale, pricing power, and regulatory moat of a leading CDMO or medical compounder.
COMPANY DESCRIPTION
Medimaging Integrated Solution Inc. designs and manufactures digital diagnostic hand-held devices, including digital otoscopes, ophthalmoscopes, and dermascopes. The company is a pioneer in integrating AI-assisted diagnostic software with portable medical imaging hardware for telemedicine. It operates as an innovative medical device manufacturer addressing the growing global demand for remote healthcare and primary care diagnostics.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | 15.9M | 17.0M | 17.0M | 20.9M | 9.6% |
| EPS | 0.06 | 0.06 | 0.06 | 0.00 | — | -58.1% |
| Shares | — | 37.4M | 38.6M | 38.8M | 38.2M | +2.3% |
| Debt | — | 2.8M | 12.8M | 14.0M | 21.3M | 97.3% |
| Equity | — | 20.5M | 25.0M | 23.5M | 23.6M | 4.8% |
| Op CF | — | 3.6M | 5.3M | -1.6M | -0.5M | 49.8% |
| Inv CF | — | -3.2M | -10.4M | 0.2M | -1.3M | — |
| Fin CF | — | 1.3M | 11.4M | -1.8M | 6.9M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 6796.TW are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 6796.TW | Medimaging Integrated Solution Inc.(you) | $75M | 12 | STRONG SELL |
| 6934.TW | HCMED INNOVATIONS CO LTD | $78M | 4 | STRONG SELL |
| 4155.TW | OK Biotech Co., Ltd. | $67M | 66 | BUY |
| 6918.TW | A Plus Biotechnology Co., Ltd. | $80M | 74 | BUY |
| 7799.TW | Heron Neutron Medical Corp. | $1.9B | 13 | STRONG SELL |
| 4129.TWO | United Orthopedic Corporation | $275M | 64 | HOLD |
| 4106.TW | Wellell Inc. | $74M | 91 | STRONG BUY |
| 6861.TW | InnoCare Optoelectronics Corporation | $497M | 72 | BUY |
| 6733.TWO | BioGend Therapeutics Co., Ltd. | $102M | 12 | STRONG SELL |
| 6709.TWO | Advagene Biopharma Co., Ltd. | $54M | 13 | STRONG SELL |
Peer medians: ROE 3.6% · P/E 16.0x · Gross margin 42.1%